AstraZeneca PLC (AZN)

Featured here, the Balance Sheet for AstraZeneca PLC, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

1,520.5 +9.5 (+0.63%)

22/09 Close SEK Disclaimer

AZN Balance Sheet

Total Current Assets

Name	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022
Total Current Assets	22,839	22,266	22,593	20,224	20,917
Cash and Short Term Investments	6,462	6,244	4,522	4,887	-
Cash	-	-	-	-	-
Cash & Equivalents	5,664	6,232	6,166	4,458	4,817
Short Term Investments	148	230	64	64	70
Total Receivables, Net	11,932	10,797	9,923	10,061	9,612
Accounts Receivables - Trade, Net	11,092	10,289	7,212	9,336	8,908
Total Inventory	5,051	4,967	4,699	5,078	6,220
Prepaid Expenses	1,329	-	-	-	-
Other Current Assets, Total	44	40	398	563	198
Total Assets	96,543	96,687	96,483	94,185	96,579
Property/Plant/Equipment, Total - Net	9,624	9,599	9,449	9,227	9,627
Property/Plant/Equipment, Total - Gross	17,192	-	-	-	-
Accumulated Depreciation, Total	-7,743	-	-	-	-
Goodwill, Net	19,960	20,001	19,820	19,707	19,821
Intangibles, Net	38,326	39,291	39,307	39,585	39,900
Long Term Investments	1,143	1,234	1,142	1,102	1,180
Note Receivable - Long Term	840	508	2,711	725	704
Other Long Term Assets, Total	915	798	909	904	994
Other Assets, Total	-2,953	-2,062	-1,485	-920	1,016
Total Current Liabilities	26,375	24,860	26,293	24,850	21,815
Accounts Payable	18,418	2,550	16,842	16,983	-
Payable/Accrued	-	-	-	-	-
Accrued Expenses	13,427	-	-	-	-
Notes Payable/Short Term Debt	421	667	5,314	743	747
Current Port. of LT Debt/Capital Leases	4,026	1,188	5,795	2,563	-
Other Current liabilities, Total	1,767	1,749	3,814	1,470	1,522
Total Liabilities	59,127	60,876	59,425	59,031	60,628
Total Long Term Debt	25,119	27,779	24,633	24,737	28,078
Long Term Debt	24,397	27,049	23,908	24,069	27,393
Capital Lease Obligations	722	730	725	668	685
Deferred Income Tax	2,800	2,795	2,944	3,479	5,275
Minority Interest	24	22	21	20	19
Other Liabilities, Total	50	466	-4,057	846	386
Total Equity	37,416	35,811	37,058	35,154	35,951
Redeemable Preferred Stock, Total	-	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-	-
Common Stock, Total	387	387	387	387	387
Additional Paid-In Capital	35,163	35,159	35,155	35,137	35,134
Retained Earnings (Accumulated Deficit)	-1,825	3,120	-2,471	-1,657	-
Treasury Stock - Common	-	-	-	-	-
ESOP Debt Guarantee	-	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-	-
Other Equity, Total	2,100	2,090	-1,604	2,101	2,087
Total Liabilities & Shareholders' Equity	96,543	96,687	96,483	94,185	96,579
Total Common Shares Outstanding	1,550	1,549	1,549.80	1,548	1,549
Total Preferred Shares Outstanding	-	-	-	-	-

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.